McKesson (MCK) Surpasses Market Returns: Some Facts Worth Knowing

McKesson (MCK) recently outperformed broader markets, with shares gaining 1.36% daily and 12.36% monthly, exceeding the S&P 500 and Medical sector. The company anticipates robust growth for its upcoming November 5, 2025 earnings report, projecting Q4 EPS to increase 26.17% to $8.92 and revenue by 11.76% to $104.66 billion, alongside a 2.45% rise in recent consensus EPS estimates. While trading at a Forward P/E of 20.38, a premium to its industry, its PEG ratio of 1.4 suggests a more balanced valuation considering its growth prospects, with a current Zacks Rank of #3 (Hold).

Analysis

McKesson (MCK) has demonstrated strong market outperformance, closing at $786.00 with a daily gain of +1.36%, significantly outpacing the S&P 500's +0.53%. Over the past month, MCK shares surged 12.36%, substantially exceeding the Medical sector's 2.87% and the S&P 500's 0.71% gains, indicating robust investor confidence and momentum.

The company's upcoming earnings report on November 5, 2025, projects substantial growth, with Q4 EPS expected to rise 26.17% year-over-year to $8.92 per share and revenue forecast to increase 11.76% to $104.66 billion. Full-year estimates also anticipate strong growth, with EPS projected at $38.05 (+15.13%) and revenue at $409.17 billion (+13.96%), supported by a 2.45% upward revision in consensus EPS estimates over the last 30 days.

Despite trading at a Forward P/E of 20.38, which represents a premium compared to its industry average of 12.9, MCK's PEG ratio of 1.4 is below the industry average of 1.53, suggesting a more balanced valuation when accounting for its expected earnings growth. The Medical - Dental Supplies industry, where MCK operates, holds a Zacks Industry Rank of 94, placing it in the top 39% of all industries, which historically indicates a favorable operating environment.

McKesson currently holds a Zacks Rank of #3 (Hold), reflecting a neutral outlook based on recent analyst estimate revisions. This rank, combined with the positive industry backdrop and strong growth projections, suggests that the stock's current valuation may be justified by its fundamental strength and growth trajectory.

Key Decisions for Investors

• Investors should closely monitor McKesson's upcoming earnings disclosure on November 5, 2025, to validate the strong projected EPS and revenue growth rates.
• While MCK trades at a P/E premium, its favorable PEG ratio suggests growth is reasonably priced, warranting a deeper look into the sustainability of its projected earnings trajectory.
• Given the Zacks Rank #3 (Hold) and the stock's recent outperformance, investors might consider maintaining existing positions and observing further developments in analyst revisions and market sentiment.
• The strong industry rank provides a supportive backdrop, but investors should assess if McKesson's individual performance can continue to outpace its peers within this favorable environment.